Codexis (CDXS) Deferred Taxes (2014 - 2017)

Codexis' (CDXS) quarterly Deferred Taxes came in at $52000.0 in Q3 2017, down 80.23% quarter-over-quarter from $263000.0 in Q3 2015.

Codexis (CDXS) Deferred Taxes (2014 - 2017) Analysis & Trends

Codexis' Deferred Taxes history runs 3 years deep, the most recent figure standing at $52000.0 for Q3 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -188,883.60
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -65.30 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 96.00 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Codexis 180.63 Mn 115.49 Mn 13.18 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2017 52,000.00
Sep 30, 2015 263,000.00
Sep 30, 2014 160,000.00